Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

11.47
-0.1800-1.55%
Post-market: 11.470.00000.00%17:16 EST
Volume:88.65K
Turnover:1.02M
Market Cap:316.08M
PE:-0.52
High:11.80
Open:11.40
Low:11.04
Close:11.65
52wk High:30.99
52wk Low:8.72
Shares:27.56M
Float Shares:10.87M
Volume Ratio:0.36
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-21.9706
EPS(LYR):-3.3635
ROE:-182.66%
ROA:-73.99%
PB:4.36
PE(LYR):-3.41

Loading ...

Crescent Biopharma Grants 24,600-Share Inducement Stock Options to New Hires

Reuters
·
Feb 19

BUZZ-U.S. STOCKS ON THE MOVE-Copper miners, Fresh Del Monte Produce, Crescent Biopharma

Reuters
·
Feb 19

BUZZ-Crescent Biopharma rises as global trial for new cancer drug starts

Reuters
·
Feb 19

Crescent Biopharma announces first patient dosed in ASCENT Phase 1/2 trial

TIPRANKS
·
Feb 18

Crescent Biopharma Doses First Patient in ASCEND Phase 1/2 Trial of CR-001 for Advanced Solid Tumors

Reuters
·
Feb 18

Crescent Biopharma Inc: Ascend Is First of Four Clinical Trials Across Portfolio Expected to Initiate in 2026

THOMSON REUTERS
·
Feb 18

Crescent Biopharma Announces First Patient Dosed in Ascend Phase 1/2 Clinical Trial of Cr-001 for the Treatment of Advanced Solid Tumors

THOMSON REUTERS
·
Feb 18

Crescent Biopharma Inc: Anticipates Reporting Proof-of-Concept Data in Q1 of 2027

THOMSON REUTERS
·
Feb 18

Crescent Biopharma Grants Stock Options to New Employees Under Inducement Plan

Reuters
·
Jan 31

Crescent Biopharma initiated with an Overweight at Piper Sandler

TIPRANKS
·
Jan 28

Crescent Biopharma Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $35

THOMSON REUTERS
·
Jan 28

BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies

Reuters
·
Jan 21

BUZZ-U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s Famous

Reuters
·
Jan 21

This Crescent Biopharma Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Benzinga
·
Jan 21

Crescent Biopharma Initiated at Buy by Guggenheim

Dow Jones
·
Jan 21

Guggenheim Initiates Crescent Biopharma at Buy With $35 Price Target

MT Newswires Live
·
Jan 21

BUZZ-Guggenheim initiates coverage on Crescent Biopharma with 'buy'

Reuters
·
Jan 21

Crescent Biopharma initiated with a Buy at Guggenheim

TIPRANKS
·
Jan 21

Crescent Biopharma Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $35

THOMSON REUTERS
·
Jan 21

LifeSci Capital Reaffirms Their Buy Rating on Crescent Biopharma (CBIO)

TIPRANKS
·
Jan 20